Case Study

Biotalent
icon_8
Overview
We assisted Trinnovo Group with the sale of BioTalent. The Shareholders entrusted Optima with the task of navigating a complex process as we faced late nights and intricate challenges as we carved out one of their brands from a group structure.
icon_9

Approach

This was an unusual transaction as we had to carve out a brand that had no separate legal entity and no separate sets of financial statements
—–
Some specific issues arose due to BioTalent operating in the US and Switzerland, as well as the UK
—–
We helped shareholders navigate a complex deal structure and negotiation process
—–
We project managed the process through to completion

icon_10

Result

We successfully completed the sale of BioTalent, the business was integrated and has become a core part of the offering today.
CLIENT FEEDBACK
“Philip’s insight was invaluable. I instructed Philip and Optima on the sale of our pharmaceutical business. At the time we had both private equity and trade offers. Philip’s insight was invaluable in selecting the right path for Trinnovo Group. Throughout what was a highly complex process of hiving out one of our brands from a group structure, Philip was logical, methodical, systematic in his process and uncovered any issues well in advance of the acquirer uncovering them, leading to a fluid and straightforward and successful process – there were some very late nights involved and Philip was absolutely on point throughout. I would highly recommend Philip and Optima”.
Ashley Lawrence
Group CEO of Trinnovo